Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
60.56
-0.21 (-0.35%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 119.53 | 199.16 | 142.71 | 148.64 | 57.24 | 175.69 |
Short-Term Investments | 811.16 | 349.72 | 484.19 | 489.44 | 534.85 | 376.09 |
Cash & Short-Term Investments | 930.69 | 548.89 | 626.91 | 638.08 | 592.09 | 551.77 |
Cash Growth | 90.89% | -12.45% | -1.75% | 7.77% | 7.31% | 211.74% |
Accounts Receivable | - | - | - | 0.87 | 0.99 | 2.77 |
Other Receivables | 1.63 | 1.37 | 1.47 | - | - | - |
Receivables | 1.63 | 1.37 | 1.47 | 0.87 | 0.99 | 2.77 |
Prepaid Expenses | 13.55 | 10.39 | 6.89 | 6.01 | 7.23 | 4.48 |
Total Current Assets | 945.87 | 560.65 | 635.26 | 644.96 | 600.3 | 559.02 |
Property, Plant & Equipment | 13.16 | 15.35 | 18.22 | 18.85 | 16.91 | 12.52 |
Long-Term Investments | 314.41 | 37.15 | 127.5 | 292.79 | 128.68 | - |
Long-Term Deferred Tax Assets | 14.36 | 12.86 | 9.67 | 0.8 | 0.51 | 0.47 |
Other Long-Term Assets | 7.97 | 7.15 | 7.5 | 7.4 | 7.75 | - |
Total Assets | 1,296 | 633.16 | 798.14 | 964.8 | 754.15 | 572.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.48 | 3.89 | 5.07 | 8.6 | 8.49 | 3.82 |
Accrued Expenses | 40.25 | 36.06 | 23.47 | 17.03 | 13.38 | 9.78 |
Current Portion of Leases | 1.34 | 1.53 | 1.37 | 1.3 | 0.49 | 0.61 |
Current Income Taxes Payable | 0.94 | 0.31 | 5.69 | 0.35 | - | - |
Other Current Liabilities | - | - | - | - | 0.34 | 0.12 |
Total Current Liabilities | 45.01 | 41.79 | 35.59 | 27.27 | 22.7 | 14.32 |
Long-Term Leases | 5.08 | 6.41 | 7.65 | 9.6 | 9.95 | 7.65 |
Other Long-Term Liabilities | 3.29 | 3.2 | - | - | - | - |
Total Liabilities | 53.38 | 51.4 | 43.24 | 36.88 | 32.65 | 21.97 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,427 | 1,599 | 1,457 | 1,436 | 1,065 | 790.9 |
Additional Paid-In Capital | 276.85 | 228.23 | 199.15 | 156.76 | 142.11 | 117.5 |
Retained Earnings | -1,458 | -1,245 | -899.47 | -665.14 | -482.75 | -357.37 |
Comprehensive Income & Other | -2.66 | 0.34 | -1.61 | -0.08 | -3 | -0.99 |
Shareholders' Equity | 1,242 | 581.76 | 754.9 | 927.92 | 721.5 | 550.03 |
Total Liabilities & Equity | 1,296 | 633.16 | 798.14 | 964.8 | 754.15 | 572.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.42 | 7.94 | 9.02 | 10.9 | 10.44 | 8.26 |
Net Cash (Debt) | 1,239 | 578.09 | 745.39 | 919.97 | 710.33 | 543.52 |
Net Cash Growth | 101.04% | -22.44% | -18.98% | 29.51% | 30.69% | 212.94% |
Net Cash Per Share | 14.31 | 7.29 | 9.57 | 13.75 | 11.73 | 12.46 |
Filing Date Shares Outstanding | 96.84 | 83.19 | 76.54 | 75.43 | 63.04 | 52.94 |
Total Common Shares Outstanding | 96.75 | 80.01 | 76.42 | 75.37 | 62.59 | 52.65 |
Working Capital | 900.86 | 518.86 | 599.67 | 617.69 | 577.6 | 544.7 |
Book Value Per Share | 12.84 | 7.27 | 9.88 | 12.31 | 11.53 | 10.45 |
Tangible Book Value | 1,242 | 581.76 | 754.9 | 927.92 | 721.5 | 550.03 |
Tangible Book Value Per Share | 12.84 | 7.27 | 9.88 | 12.31 | 11.53 | 10.45 |
Machinery | - | 14.76 | 14.38 | 11.89 | 11 | 10.8 |
Leasehold Improvements | - | 9.41 | 9.36 | 9.02 | 4.2 | 7.02 |